|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000166619 |
Summary for BLCAP |
Gene summary |
| Gene information | Ensembl ID | ENSG00000166619 | Gene symbol | BLCAP |
| Gene name | BLCAP apoptosis inducing factor | |
| HGNC | 1055 | |
| Entrez ID | 10904 | |
| Gene type | protein_coding | |
| Synonyms | BLCAP|BC10 | |
| UniProtAcc | P62952 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for BLCAP |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| BLCAP | 7.39e+03 | 1.01e+00 | 1.22e-01 | 8.26e+00 | 1.44e-16 | 5.63e-16 | LUSC |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for BLCAP |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for BLCAP |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| ACC | cg21733794 | chr20:37525986 | CGI:chr20:37527620-37528267 | promoter,gene body | 7.09e-01 | 8.22e-01 | -2.94e+00 | 3.26e-03 | 1.30e-02 | -1.13e-01 |
| CHOL | cg01082601 | chr20:37528558 | CGI:chr20:37527620-37528267 | promoter | 5.67e-01 | 4.56e-01 | 2.07e+00 | 3.85e-02 | 4.47e-02 | 1.12e-01 |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LUSC | cg21733794 | chr20:37525986 | CGI:chr20:37527620-37528267 | promoter,gene body | 4.26e-01 | 6.27e-01 | -3.76e+00 | 1.68e-04 | 8.86e-04 | -2.01e-01 |
| LUSC | cg00965133 | chr20:37529175 | CGI:chr20:37527620-37528267 | promoter | 6.93e-01 | 8.13e-01 | -2.73e+00 | 6.39e-03 | 9.82e-03 | -1.19e-01 |
| BLCA | cg00216901 | chr20:37528517 | CGI:chr20:37527620-37528267 | promoter | 4.93e-01 | 3.71e-01 | 3.21e+00 | 1.31e-03 | 2.81e-03 | 1.22e-01 |
| BLCA | cg06133908 | chr20:37528534 | CGI:chr20:37527620-37528267 | promoter | 7.70e-01 | 6.68e-01 | 2.88e+00 | 3.96e-03 | 6.75e-03 | 1.02e-01 |
| BLCA | cg21863334 | chr20:37529003 | CGI:chr20:37527620-37528267 | promoter | 5.23e-01 | 6.41e-01 | -2.93e+00 | 3.43e-03 | 6.03e-03 | -1.18e-01 |
| BLCA | cg00965133 | chr20:37529175 | CGI:chr20:37527620-37528267 | promoter | 6.87e-01 | 8.50e-01 | -4.09e+00 | 4.27e-05 | 2.23e-04 | -1.63e-01 |
| CHOL | cg20703564 | chr20:37528614 | CGI:chr20:37527620-37528267 | promoter | 9.77e-02 | 2.73e-01 | -3.54e+00 | 4.02e-04 | 8.32e-03 | -1.75e-01 |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg21733794 | chr20:37525986 | CGI:chr20:37527620-37528267 | promoter,gene body | 7.19e-01 | 5.71e-01 | 1.20e+01 | 4.95e-33 | 1.07e-31 | 1.48e-01 |
| BRCA | cg00216901 | chr20:37528517 | CGI:chr20:37527620-37528267 | promoter | 5.89e-01 | 4.11e-01 | 1.20e+01 | 2.06e-33 | 4.74e-32 | 1.78e-01 |
| BRCA | cg21863334 | chr20:37529003 | CGI:chr20:37527620-37528267 | promoter | 6.45e-01 | 5.16e-01 | 1.16e+01 | 4.45e-31 | 7.42e-30 | 1.29e-01 |
| KIRC | cg06133908 | chr20:37528534 | CGI:chr20:37527620-37528267 | promoter | 6.36e-01 | 5.34e-01 | 2.00e+00 | 4.59e-02 | 4.71e-02 | 1.02e-01 |
| COAD | cg21863334 | chr20:37529003 | CGI:chr20:37527620-37528267 | promoter | 6.39e-01 | 7.44e-01 | -3.72e+00 | 1.99e-04 | 1.00e-03 | -1.04e-01 |
| COAD | cg00965133 | chr20:37529175 | CGI:chr20:37527620-37528267 | promoter | 7.38e-01 | 8.39e-01 | -3.69e+00 | 2.26e-04 | 1.09e-03 | -1.01e-01 |
| LIHC | cg19650416 | chr20:37528606 | CGI:chr20:37527620-37528267 | promoter | 1.21e-01 | 2.45e-01 | -5.63e+00 | 1.83e-08 | 1.01e-06 | -1.25e-01 |
| KIRP | cg06133908 | chr20:37528534 | CGI:chr20:37527620-37528267 | promoter | 6.24e-01 | 4.78e-01 | 2.45e+00 | 1.41e-02 | 2.12e-02 | 1.45e-01 |
Top |
Exon skipping events with PSI in TCGA for BLCAP |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for BLCAP |
| ∗Please access CAeditome for RNA editing annotation. |
Landscape of RNA editing events across multiple cancer types. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| COAD | BLCAP-002 | chr20_37519678_- | 5.60e-01 | 4.07e-01 | 2.60e+00 | 9.31e-03 | 2.18e-02 | 1.53e-01 |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for BLCAP |
TFs related to BLCAP.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
BLCAP related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for BLCAP |
RBPs related to ES in BLCAP.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
BLCAP related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
| ENSG00000166619 | LINC01409,hsa-mir-431,BLCAP | Male-specific ceRNA | TCGA-LUSC |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs58925751 | chr20:31459409:A:T | - | 0.104863599281371 | 0.0421782195678164 | HNSC | Female-baised eQTL |
| rs145997915 | chr20:31453699:G:A | - | 0.105125016230353 | 0.0481921002083814 | HNSC | Female-baised eQTL |
| rs73116268 | chr20:31461103:G:A | - | 0.105125016230353 | 0.0481921002083814 | HNSC | Female-baised eQTL |
| rs73116272 | chr20:31467430:A:T | - | 0.105227145679991 | 0.0484581695100283 | HNSC | Female-baised eQTL |
| rs78070351 | chr20:35313471:G:A | - | 0.152575797256886 | 0.0112487786793214 | LUSC | Female-baised eQTL |
| rs59563213 | chr20:39479190:G:A | - | 0.171149606500437 | 0.0149170556447719 | LUSC | Female-baised eQTL |
| rs6059199 | chr20:33252605:A:G | - | 0.117649271305487 | 0.0179694687397989 | LUSC | Female-baised eQTL |
| rs74887150 | chr20:42395861:G:A | - | 0.168635927158781 | 0.00108066445036104 | KIRC | Female-baised eQTL |
| rs79010180 | chr20:42395924:C:T | - | 0.168635927158781 | 0.00108066445036104 | KIRC | Female-baised eQTL |
| rs78383928 | chr20:42395990:G:T | - | 0.168635927158781 | 0.00108066445036104 | KIRC | Female-baised eQTL |
| rs77498071 | chr20:42396111:G:A | - | 0.168635927158781 | 0.00108066445036104 | KIRC | Female-baised eQTL |
| rs78592176 | chr20:42396257:C:A | - | 0.168635927158781 | 0.00108066445036104 | KIRC | Female-baised eQTL |
| rs728331 | chr20:40358946:G:A | - | 0.115285141825848 | 0.00118871632412964 | KIRC | Female-baised eQTL |
| rs819144 | chr20:34273750:T:G | - | -0.0921696402741102 | 0.00312517928944913 | KIRC | Female-baised eQTL |
| rs6030192 | chr20:42387852:C:T | - | 0.157494247379203 | 0.00358107827179078 | KIRC | Female-baised eQTL |
| rs7268865 | chr20:40276962:T:A | - | 0.11262525230678 | 0.00418455064009341 | KIRC | Female-baised eQTL |
| rs7272826 | chr20:31388600:A:T | - | 0.146786084986783 | 0.00769671673667545 | KIRC | Female-baised eQTL |
| rs6029061 | chr20:40360133:A:G | - | 0.10065195102763 | 0.00816071851379508 | KIRC | Female-baised eQTL |
| rs35345275 | chr20:40356657:T:C | - | 0.105812495863863 | 0.0092826317076365 | KIRC | Female-baised eQTL |
| rs35057624 | chr20:40369187:G:C | - | 0.103984974459124 | 0.0110326262059764 | KIRC | Female-baised eQTL |
| rs6029073 | chr20:40369970:C:T | - | 0.103984974459124 | 0.0110326262059764 | KIRC | Female-baised eQTL |
| rs6029075 | chr20:40371729:A:G | - | 0.103984974459124 | 0.0110326262059764 | KIRC | Female-baised eQTL |
| rs16985167 | chr20:40377052:C:T | - | 0.103984974459124 | 0.0110326262059764 | KIRC | Female-baised eQTL |
| rs79687048 | chr20:42393489:A:C | - | 0.143805734362387 | 0.0115931331358311 | KIRC | Female-baised eQTL |
| rs6016329 | chr20:40356365:G:A | - | 0.103757953241257 | 0.0117819411206466 | KIRC | Female-baised eQTL |
| rs80129688 | chr20:42367555:A:G | - | 0.139192751306077 | 0.0144349927006309 | KIRC | Female-baised eQTL |
| rs1156806 | chr20:42386077:C:A | - | 0.150851492184326 | 0.0147252417735108 | KIRC | Female-baised eQTL |
| rs11906988 | chr20:38383368:T:G | - | 0.131998243443353 | 0.0160335835045557 | KIRC | Female-baised eQTL |
| rs6030230 | chr20:42432735:C:A | - | 0.0777333428508821 | 0.0193971085250116 | KIRC | Female-baised eQTL |
| rs2224282 | chr20:40360387:C:G | - | 0.0969088681763666 | 0.0197823518659651 | KIRC | Female-baised eQTL |
| rs6016332 | chr20:40360206:A:T | - | 0.097698402342848 | 0.019987067621032 | KIRC | Female-baised eQTL |
| rs1969696 | chr20:40361232:T:C | - | 0.097698402342848 | 0.019987067621032 | KIRC | Female-baised eQTL |
| rs1535208 | chr20:40361323:G:A | - | 0.097698402342848 | 0.019987067621032 | KIRC | Female-baised eQTL |
| rs35975195 | chr20:40367810:G:T | - | 0.097698402342848 | 0.019987067621032 | KIRC | Female-baised eQTL |
| rs6029078 | chr20:40373360:A:T | - | 0.097698402342848 | 0.019987067621032 | KIRC | Female-baised eQTL |
| rs6029079 | chr20:40375244:A:G | - | 0.097698402342848 | 0.019987067621032 | KIRC | Female-baised eQTL |
| rs8119759 | chr20:40376742:T:G | - | 0.097698402342848 | 0.019987067621032 | KIRC | Female-baised eQTL |
| rs7273715 | chr20:40378655:A:C | - | 0.097698402342848 | 0.019987067621032 | KIRC | Female-baised eQTL |
| rs41448645 | chr20:42366494:G:A | - | 0.130078729834896 | 0.0272132545897333 | KIRC | Female-baised eQTL |
| rs6064720 | chr20:38570215:C:T | - | 0.131887813900176 | 0.0284285992031318 | KIRC | Female-baised eQTL |
| rs6064651 | chr20:38522193:A:G | - | 0.126248112425068 | 0.0354779860798705 | KIRC | Female-baised eQTL |
| rs6064653 | chr20:38524400:G:A | - | 0.12782801571016 | 0.0360234209618822 | KIRC | Female-baised eQTL |
| rs6064680 | chr20:38542622:A:G | - | 0.12741315151658 | 0.0373652073731101 | KIRC | Female-baised eQTL |
| rs6070535 | chr20:38542704:A:G | - | 0.12741315151658 | 0.0373652073731101 | KIRC | Female-baised eQTL |
| rs6070565 | chr20:38553525:A:G | - | 0.12741315151658 | 0.0373652073731101 | KIRC | Female-baised eQTL |
| rs6070622 | chr20:38562812:A:G | - | 0.12741315151658 | 0.0373652073731101 | KIRC | Female-baised eQTL |
| rs819173 | chr20:34278756:C:T | - | -0.080028010886427 | 0.0373842697451895 | KIRC | Female-baised eQTL |
| rs819172 | chr20:34279700:T:C | - | -0.080028010886427 | 0.0373842697451895 | KIRC | Female-baised eQTL |
| rs819171 | chr20:34280178:C:T | - | -0.080028010886427 | 0.0373842697451895 | KIRC | Female-baised eQTL |
| rs819169 | chr20:34280231:G:A | - | -0.080028010886427 | 0.0373842697451895 | KIRC | Female-baised eQTL |
| rs819133 | chr20:34282508:T:G | - | -0.080028010886427 | 0.0373842697451895 | KIRC | Female-baised eQTL |
| rs13036892 | chr20:40289055:T:G | - | 0.0942664930094403 | 0.0390019815104097 | KIRC | Female-baised eQTL |
| rs13042092 | chr20:40318568:A:T | - | 0.0950552245448623 | 0.0406048585285534 | KIRC | Female-baised eQTL |
| rs716431 | chr20:36240537:T:C | - | 0.116466462513769 | 0.0414570011602436 | KIRC | Female-baised eQTL |
| rs6092639 | chr20:38517732:A:G | - | 0.123978848455293 | 0.0442796914758822 | KIRC | Female-baised eQTL |
| rs6070459 | chr20:38522075:G:A | - | 0.123978848455293 | 0.0442796914758822 | KIRC | Female-baised eQTL |
| rs16987373 | chr20:38528232:A:G | - | 0.125569932230713 | 0.0448334003203697 | KIRC | Female-baised eQTL |
| rs6100096 | chr20:38533360:G:C | - | 0.12517141967461 | 0.0464529043933153 | KIRC | Female-baised eQTL |
| rs6070623 | chr20:38563144:T:G | - | 0.12517141967461 | 0.0464529043933153 | KIRC | Female-baised eQTL |
| rs6070626 | chr20:38563267:C:T | - | 0.12517141967461 | 0.0464529043933153 | KIRC | Female-baised eQTL |
| rs2179664 | chr20:38569024:T:C | - | 0.12517141967461 | 0.0464529043933153 | KIRC | Female-baised eQTL |
| rs6070643 | chr20:38570407:A:G | - | 0.12517141967461 | 0.0464529043933153 | KIRC | Female-baised eQTL |
| rs6070663 | chr20:38577249:T:C | - | 0.12517141967461 | 0.0464529043933153 | KIRC | Female-baised eQTL |
| rs111550550 | chr20:47438565:C:T | - | 0.0885679618703335 | 0.00116805350977502 | LUAD | Female-baised eQTL |
| rs113651950 | chr20:47437679:T:C | - | 0.0883720333677311 | 0.00121861891306138 | LUAD | Female-baised eQTL |
| rs78477402 | chr20:47438320:A:C | - | 0.0883720333677311 | 0.00121861891306138 | LUAD | Female-baised eQTL |
| rs6125019 | chr20:47439714:C:T | - | 0.0883720333677311 | 0.00121861891306138 | LUAD | Female-baised eQTL |
| rs8119756 | chr20:44641361:A:G | - | 0.0628798620460236 | 0.0298275076422178 | LUAD | Female-baised eQTL |
| rs55800632 | chr20:44641459:A:G | - | 0.0626034493680259 | 0.0336901052246229 | LUAD | Female-baised eQTL |
| rs8119702 | chr20:44641285:A:T | - | 0.0630073735799511 | 0.0338971370980361 | LUAD | Female-baised eQTL |
| rs2425938 | chr20:47451532:A:G | - | 0.0502402302803886 | 0.0444231359939034 | LUAD | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs6094286 | chr20:46376791:T:C | - | 0.0920312633407355 | 0.0117537272914778 | COAD | Male-baised eQTL |
| rs6060820 | chr20:36146240:T:C | - | 0.0963136620961486 | 0.0456683654865314 | COAD | Male-baised eQTL |
| rs4810511 | chr20:46499106:G:A | - | 0.0494569812506489 | 0.0470397697975148 | COAD | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg17820025 | chr20:37524411 | gene,exon,UTR | -0.425659740241302 | 3.75298603595014e-15 | -0.568828478028826 | 1.2589855573980387e-18 | KIRP |
| cg18244708 | chr20:37524521 | gene,exon,UTR | -0.425659740241302 | 3.75298603595014e-15 | -0.568828478028826 | 1.2589855573980387e-18 | KIRP |
| cg01604401 | chr20:37524784 | gene | -0.425659740241302 | 3.75298603595014e-15 | -0.568828478028826 | 1.2589855573980387e-18 | KIRP |
| cg24890964 | chr20:37525240 | gene | -0.425659740241302 | 3.75298603595014e-15 | -0.568828478028826 | 1.2589855573980387e-18 | KIRP |
| cg21733794 | chr20:37525986 | gene,promoter | -0.256895806337138 | 4.43469360884192e-10 | -0.48557073741152745 | 2.7495532680964833e-13 | KIRP |
| cg24214471 | chr20:37525890 | gene | -0.121923819061582 | 3.6038647126198e-05 | -0.3680730722074523 | 7.628129291950615e-08 | KIRP |
| cg22551578 | chr20:37520218 | gene | -0.385780864004408 | 1.87032753839457e-05 | -0.3255439129554921 | 1.2442505488609495e-07 | LIHC |
| cg11948874 | chr20:37518925 | gene,exon,CDS | -0.385698763132185 | 1.87946180524464e-05 | -0.32547525824613893 | 1.1818894516858466e-07 | LIHC |
| cg20479660 | chr20:37520710 | gene | -0.385698763132185 | 1.87946180524464e-05 | -0.32547525824613893 | 1.1818894516858466e-07 | LIHC |
| cg16648571 | chr20:37520829 | gene | -0.385698763132185 | 1.87946180524464e-05 | -0.32547525824613893 | 1.1818894516858466e-07 | LIHC |
| cg04810287 | chr20:37520869 | gene | -0.385698763132185 | 1.87946180524464e-05 | -0.32547525824613893 | 1.1818894516858466e-07 | LIHC |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of BLCAP |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |